Megan Schutt Receives Two-Match Suspension Over Medication Protocol Breach

Published: October 23, 2026, 3:52 am

Australian cricketer Megan Schutt has been issued a two-match suspension for failing to comply with protocols concerning prescription medication. Cricket Australia confirmed that the breach involved a failure to adhere to the mandatory requirements established under the Sports Science and Sports Medicine guidelines. Officials clarified that the incident took place while the player was out of competition and was entirely unrelated to performance enhancement.

The suspension will result in the 33-year-old missing the third and final T20I match against New Zealand, scheduled for Thursday, October 22, at North Sydney Oval. Furthermore, she will be sidelined for the Adelaide Strikers’ opening match of the WBBL 2026 season against the Melbourne Stars on October 31. Cricket Australia stated they would continue to offer support to Schutt while emphasizing the importance of upholding the standards expected of all representatives of the game. I’m sorry for the attention this has caused and appreciate the support I’ve received,” the 33-year-old added. “While this occurred out of competition and was not performance related, I understand that I am responsible f. Whichever comes first, the ban applies to all international and domestic cricket.

In a personal statement, Schutt accepted the penalty and expressed regret for her actions. She acknowledged that she failed to meet the necessary standards, noting that players receive regular education regarding these guidelines. The pacer apologized for the unwanted attention the situation has generated, stating that she understands her personal responsibility in following the established medical protocols.

The governing body reiterated that it would reinforce these professional responsibilities to ensure all participants are aligned with current policies. Schutt concluded by thanking those who have provided support during this period as she prepares to serve the imposed ban.